Charles Schwab Investment Management Inc Cerus Corp Transaction History

Charles Schwab Investment Management Inc

  • $515 Billion
  • Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Cerus Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,754,540 shares of CERS stock, worth $2.91 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,754,540
Previous 1,745,833 0.5%
Holding current value
$2.91 Million
Previous $3.07 Million 0.65%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$1.7 - $2.39 $14,801 - $20,809
8,707 Added 0.5%
1,754,540 $3.05 Million
Q2 2024

Aug 12, 2024
BUY
$1.62 - $2.04 $63,732 - $80,255
39,341 Added 2.31%
1,745,833 $3.07 Million
Q1 2024

May 08, 2024
BUY
$1.66 - $2.42 $82,727 - $120,603
49,836 Added 3.01%
1,706,492 $3.23 Million
Q4 2023

Feb 06, 2024
SELL
$1.25 - $2.35 $31,637 - $59,478
-25,310 Reduced 1.5%
1,656,656 $3.58 Million
Q3 2023

Nov 08, 2023
BUY
$1.5 - $3.07 $109,041 - $223,170
72,694 Added 4.52%
1,681,966 $2.72 Million
Q2 2023

Aug 09, 2023
BUY
$1.79 - $2.9 $68,329 - $110,701
38,173 Added 2.43%
1,609,272 $3.96 Million
Q1 2023

May 11, 2023
SELL
$2.65 - $3.81 $25,182 - $36,206
-9,503 Reduced 0.6%
1,571,099 $4.67 Million
Q4 2022

Feb 13, 2023
BUY
$3.38 - $4.22 $93,832 - $117,151
27,761 Added 1.79%
1,580,602 $5.77 Million
Q3 2022

Nov 14, 2022
BUY
$3.43 - $5.83 $393,904 - $669,523
114,841 Added 7.99%
1,552,841 $5.59 Million
Q2 2022

Aug 15, 2022
BUY
$4.41 - $5.69 $859,980 - $1.11 Million
195,007 Added 15.69%
1,438,000 $7.61 Million
Q1 2022

May 13, 2022
BUY
$4.81 - $6.99 $151,058 - $219,520
31,405 Added 2.59%
1,242,993 $6.83 Million
Q4 2021

Feb 11, 2022
BUY
$5.97 - $7.93 $149,184 - $198,162
24,989 Added 2.11%
1,211,588 $8.25 Million
Q3 2021

Nov 16, 2021
SELL
$4.79 - $6.68 $504,837 - $704,031
-105,394 Reduced 8.16%
1,186,599 $7.23 Million
Q2 2021

Aug 16, 2021
BUY
$5.35 - $6.35 $242,665 - $288,023
45,358 Added 3.64%
1,291,993 $7.64 Million
Q1 2021

May 17, 2021
BUY
$5.68 - $7.87 $882,234 - $1.22 Million
155,323 Added 14.23%
1,246,635 $7.49 Million
Q4 2020

Feb 16, 2021
BUY
$5.25 - $8.56 $101,010 - $164,694
19,240 Added 1.79%
1,091,312 $7.55 Million
Q3 2020

Nov 13, 2020
SELL
$5.78 - $7.47 $137,459 - $177,651
-23,782 Reduced 2.17%
1,072,072 $6.71 Million
Q2 2020

Aug 14, 2020
BUY
$4.5 - $7.02 $423,702 - $660,975
94,156 Added 9.4%
1,095,854 $7.23 Million
Q1 2020

May 15, 2020
BUY
$2.87 - $5.49 $408,019 - $780,496
142,167 Added 16.54%
1,001,698 $4.66 Million
Q4 2019

Feb 07, 2020
BUY
$3.84 - $4.86 $83,662 - $105,884
21,787 Added 2.6%
859,531 $3.63 Million
Q3 2019

Nov 08, 2019
BUY
$4.86 - $6.05 $176,111 - $219,233
36,237 Added 4.52%
837,744 $4.32 Million
Q2 2019

Aug 09, 2019
BUY
$4.51 - $6.6 $106,742 - $156,208
23,668 Added 3.04%
801,507 $4.51 Million
Q1 2019

May 14, 2019
BUY
$5.16 - $6.85 $209,052 - $277,520
40,514 Added 5.49%
777,839 $4.85 Million
Q4 2018

Feb 14, 2019
BUY
$4.89 - $7.16 $20,088 - $29,413
4,108 Added 0.56%
737,325 $3.74 Million
Q3 2018

Nov 13, 2018
BUY
$6.89 - $7.78 $377,592 - $426,367
54,803 Added 8.08%
733,217 $5.29 Million
Q2 2018

Aug 08, 2018
BUY
$5.19 - $7.25 $262,105 - $366,139
50,502 Added 8.04%
678,414 $4.53 Million
Q1 2018

May 07, 2018
BUY
$3.56 - $5.74 $484,170 - $780,657
136,003 Added 27.65%
627,912 $3.44 Million
Q4 2017

Jan 17, 2018
BUY
$2.76 - $3.95 $248,880 - $356,187
90,174 Added 22.45%
491,909 $1.66 Million
Q3 2017

Nov 13, 2017
BUY
$2.22 - $2.73 $891,851 - $1.1 Million
401,735
401,735 $1.1 Million

Others Institutions Holding CERS

# of Institutions
155
Shares Held
147M
Call Options Held
84.2K
Put Options Held
55.5K
View Full List

About CERUS CORP

CERS Quotes by TradingView
  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $294M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email